Find Clinical Trials
Assessment of blood glucose profile in type 2 diabetic patients after a one-week treatment with gliclazide 60 mg MR using both the glycaemic Holter method and multiple blood glucose samples. A double-blind, randomized, parallel group, placebo-controlled, exploratory study.
Servier Protocol Code:
CL2-DIABE-001
Sponsor:
Institut de Recherches Internationales Servier (I.R.I.S)
EudraCT Number:
2008-002647-16
Find a recruiting site
Name:
Institut de Recherches Internationales Servier, Département des études cliniques
Phone number:
+33 1 55 72 60 00
Results
English (USA)Interventions / Treatments
The treatment(s) given to the participants in the study.
- Diabetes - Type II
- GLICLAZIDE
Other study id numbers
Other identification numbers the study may be known by.
- CL2-DIABE-001